Cardio Diagnostics Holdings, Inc. (CDIOW)
- Previous Close
0.0319 - Open
0.0309 - Bid --
- Ask --
- Day's Range
0.0308 - 0.0309 - 52 Week Range
0.0308 - 0.0309 - Volume
1,849 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 3.65
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
cdio.aiRecent News: CDIOW
View More
Compare To: CDIOW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CDIOW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-69.36%
Return on Equity (ttm)
-133.96%
Revenue (ttm)
34.89k
Net Income Avi to Common (ttm)
-8.38M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
7.83M
Total Debt/Equity (mrq)
10.15%
Levered Free Cash Flow (ttm)
-2.41M